Drugs / 177Lu-DOTA-FAPI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04849247 | Apr 2021 → Apr 2024 | — | The First Affiliated Hospital of Xiamen University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 177Lu-DOTA-FAPI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04849247 ↗ |